Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 517 to 520 of 520 entries
Sorted by: Best Match Show Resources per page
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.

Annals of the rheumatic diseases

Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ.
PMID: 33757968
Ann Rheum Dis. 2021 Mar 23; doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.

No abstract available.

Cite
Boyarsky BJ, Ruddy JA, Connolly CM, et al. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021;doi: 10.1136/annrheumdis-2021-220289.
Boyarsky, B. J., Ruddy, J. A., Connolly, C. M., Ou, M. T., Werbel, W. A., Garonzik-Wang, J. M., Segev, D. L., & Paik, J. J. (2021). Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2021-220289
Boyarsky, Brian J, et al. "Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases." Annals of the rheumatic diseases vol. (2021). doi: https://doi.org/10.1136/annrheumdis-2021-220289
Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 23; doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23. PMID: 33757968.
Copy Download .nbib Format: NLM
WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia.

Parkinsonism & related disorders

Skorvanek M, Rektorova I, Mandemakers W, Wagner M, Steinfeld R, Orec L, Han V, Pavelekova P, Lackova A, Kulcsarova K, Ostrozovicova M, Gdovinova Z, Plecko B, Brunet T, Berutti R, Kuipers DJS, Boumeester V, Havrankova P, Tijssen MAJ, Kaiyrzhanov R, Rizig M, Houlden H, Winkelmann J, Bonifati V, Zech M, Jech R.
PMID: 34890876
Parkinsonism Relat Disord. 2021 Dec 02;94:54-61. doi: 10.1016/j.parkreldis.2021.11.030. Epub 2021 Dec 02.

INTRODUCTION: Sixteen subjects with biallelic WARS2 variants encoding the tryptophanyl mitochondrial aminoacyl-tRNA synthetase, presenting with a neonatal- or infantile-onset mitochondrial disease, have been reported to date. Here we present six novel cases with WARS2-related diseases and expand the spectrum...

Cite
Skorvanek M, Rektorova I, Mandemakers W, et al. WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia. Parkinsonism Relat Disord. 2021;94:54-61doi: 10.1016/j.parkreldis.2021.11.030.
Skorvanek, M., Rektorova, I., Mandemakers, W., Wagner, M., Steinfeld, R., Orec, L., Han, V., Pavelekova, P., Lackova, A., Kulcsarova, K., Ostrozovicova, M., Gdovinova, Z., Plecko, B., Brunet, T., Berutti, R., Kuipers, D. J. S., Boumeester, V., Havrankova, P., Tijssen, M. A. J., Kaiyrzhanov, R., Rizig, M., Houlden, H., Winkelmann, J., Bonifati, V., Zech, M., & Jech, R. (2021). WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia. Parkinsonism & related disorders, 9454-61. https://doi.org/10.1016/j.parkreldis.2021.11.030
Skorvanek, Matej, et al. "WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia." Parkinsonism & related disorders vol. 94 (2021): 54-61. doi: https://doi.org/10.1016/j.parkreldis.2021.11.030
Skorvanek M, Rektorova I, Mandemakers W, Wagner M, Steinfeld R, Orec L, Han V, Pavelekova P, Lackova A, Kulcsarova K, Ostrozovicova M, Gdovinova Z, Plecko B, Brunet T, Berutti R, Kuipers DJS, Boumeester V, Havrankova P, Tijssen MAJ, Kaiyrzhanov R, Rizig M, Houlden H, Winkelmann J, Bonifati V, Zech M, Jech R. WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia. Parkinsonism Relat Disord. 2021 Dec 02;94:54-61. doi: 10.1016/j.parkreldis.2021.11.030. Epub 2021 Dec 02. PMID: 34890876.
Copy Download .nbib Format: NLM
Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.

JAMA surgery

Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM.
PMID: 34379106
JAMA Surg. 2021 Nov 01;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748.

IMPORTANCE: Traditionally, liver transplant (LT) for alcohol-associated liver disease (ALD) requires 6 months of abstinence. Although early LT before 6 months of abstinence has been associated with decreased mortality for decompensated ALD, this practice remains controversial and concentrated at...

Cite
Herrick-Reynolds KM, Punchhi G, Greenberg RS, et al. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg. 2021;156(11):1026-1034doi: 10.1001/jamasurg.2021.3748.
Herrick-Reynolds, K. M., Punchhi, G., Greenberg, R. S., Strauss, A. T., Boyarsky, B. J., Weeks-Groh, S. R., Krach, M. R., Anders, R. A., Gurakar, A., Chen, P. H., Segev, D. L., King, E. A., Philosophe, B., Ottman, S. E., Wesson, R. N., Garonzik-Wang, J. M., & Cameron, A. M. (2021). Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA surgery, 156(11), 1026-1034. https://doi.org/10.1001/jamasurg.2021.3748
Herrick-Reynolds, Kayleigh M, et al. "Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease." JAMA surgery vol. 156,11 (2021): 1026-1034. doi: https://doi.org/10.1001/jamasurg.2021.3748
Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg. 2021 Nov 01;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748. PMID: 34379106; PMCID: PMC8358815.
Copy Download .nbib Format: NLM
Does equity sensitivity moderate the relationship between effort-reward imbalance and burnout.

Oren L, Littman-Ovadia H.
UIID-AD: 2830
2013;26:643-58. doi: 10.1080/10615806.2012.753060.

The model of effort-reward imbalance (ERI) received considerable research attention in the job stress literature. However, very scarce research investigated individual differences as moderators between ERI and stress. The present study is aimed at examining the combined effects of...

Cite
Oren L, Littman-Ovadia H. Does equity sensitivity moderate the relationship between effort-reward imbalance and burnout. 2013;26:643-58doi: 10.1080/10615806.2012.753060.
Oren, L., & Littman-Ovadia, H. (2013). Does equity sensitivity moderate the relationship between effort-reward imbalance and burnout. 26643-58. https://doi.org/10.1080/10615806.2012.753060
Oren, L, and Littman-Ovadia, H. "Does equity sensitivity moderate the relationship between effort-reward imbalance and burnout." vol. 26 (2013): 643-58. doi: https://doi.org/10.1080/10615806.2012.753060
Oren L, Littman-Ovadia H. Does equity sensitivity moderate the relationship between effort-reward imbalance and burnout. 2013;26:643-58. doi: 10.1080/10615806.2012.753060. UIID-AD: 2830.
Copy Download .nbib Format: NLM
Showing 517 to 520 of 520 entries